Concord Communications

Concord Biotech is a leading global R&D-driven biopharmaceutical company based in India, specializing in the development and manufacture of fermentation-based Active Pharmaceutical Ingredients (APIs) and finished formulations. The company is a dominant player in the global immunosuppressant market, producing critical molecules such as tacrolimus, cyclosporine, and mycophenolate mofetil. Beyond immunology, Concord has a significant presence in oncology, anti-infectives, and nephrology, supplying products to over 70 countries including highly regulated markets like the United States, Europe, and Japan. With world-class manufacturing facilities approved by global regulatory bodies, the company serves as a key partner for pharmaceutical firms worldwide through its integrated CDMO and API supply capabilities.